Article
A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics.
The Journal of biological chemistry - 16 Apr 2004
Pernot Lucile, Chesnel Laurent, Le Gouellec Audrey, Croizé Jacques, Vernet Thierry, Dideberg Otto, Dessen Andréa
Abstract excerpt
The human pathogen Streptococcus pneumoniae is one of the main causative agents of respiratory tract infections. At present, clinical isolates of S. pneumoniae often exhibit decreased susceptibility toward beta-lactams, a phenomenon linked to multiple mutations within the penicillin-binding prote...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
